PolyTech Ventures

Yamo is dedicated to providing parents with healthier food choices for their children through its range of organic baby food products. The company's offerings serve as nutritious alternatives to junk food, catering to kids of all ages. Yamo operates a direct-to-consumer subscription model, allowing parents to conveniently receive products online. Additionally, its products are available in grocery stores, including Coop in Switzerland and select Edeka and Rewe locations in Germany. By focusing on quality and taste, Yamo aims to make it easier for parents to find and purchase wholesome food options for their children.

KiWi provides micro-merchants with access to appropriate digital technology, thereby contributing to a fair and competitive market. Merchants can use their KiWi app to accept card and mobile payments, gain access to microcredit, and earn more money by selling additional KiWi services and products. KiWi was founded in 2014 and has offices in Switzerland and Mexico.

CodeCheck AG is a Swiss company based in Zurich that has developed a smartphone application designed to help consumers make informed purchasing decisions. Founded in 2007, the CodeCheck app allows users to scan the barcodes of food and cosmetic products in Germany and the USA, providing detailed product descriptions, ingredient lists, and consumer reviews. It offers personalized ratings based on individual user profiles and the latest scientific research, catering to the growing demand for transparency regarding product ingredients and ethical standards. With a user base exceeding 3 million, CodeCheck taps into significant trends in conscious consumption and transparency. Additionally, the company has introduced Oeeda, a market research solution aimed at assisting manufacturers in understanding consumer preferences to drive innovation.

LEND is a peer-to-peer lending platform based in Switzerland, founded in 2015. The company connects investors with borrowers, facilitating transactions for private and small to medium-sized enterprise (SME) loans and mortgages. Through its online platform, LEND enables investors to finance borrowers directly, allowing them to build diversified portfolios by investing small amounts in multiple loans. This approach provides borrowers with access to low-interest loans while offering investors the opportunity to earn substantial returns on their investments.

Biowatch is a user-friendly wrist veins biometric reader that functions as a security solution for mobile payment protection and smart device interaction. Users can access the app for enrolling their vein pattern and selecting applications and devices that needs to be connected to their Biowatch, wear their BioWatch and activate it by matching their vein pattern with their enrolled reference, get PKI encrypted user code transmitted from their Biowatch, and start opening doors without the use of keys and passwords. Biowatch was launched by Joe Rice and Matthias Vanoni and is headquartered in Lausanne, Switzerland.

One Visage is a cyber security company that offers a digital identity platform for financial services, and identity and access management providers, and integrators and mobile operators. The company makes use of their proprietary 3DAuth digital identity technology that can be installed on any consumer mobile phone instead of the current password-based and biometric solutions. One Visage is found in 2013 and is based in Switzerland.

Altoida AG is a healthcare company based in Lucerne, Switzerland, established in 2016, focused on developing a platform and application for assessing brain health, particularly in relation to Alzheimer's disease and dementia. The company aims to transform how brain function is measured and neurological diseases are diagnosed, utilizing smartphones and tablets. Its innovative approach leverages over 20 years of research in digital biomarkers, augmented reality, and artificial intelligence. Altoida's flagship product is a Computerized Cognitive Assessment Aid, which is classified as Class II and is exempt from the 510(k) process. This application employs machine learning algorithms to evaluate patients' cognitive and functional abilities, enabling early detection of Alzheimer's and facilitating timely intervention to improve patient outcomes. In recognition of its advanced technology, Altoida received FDA Breakthrough Device Designation in July 2021.

Artmyn SA specializes in the digitization of visual artworks, offering a comprehensive platform that allows users to access high-quality digital representations of art through web browsers on various devices, including laptops, smartphones, and tablets. Founded in 2015 and based in Belmont-sur-Lausanne, Switzerland, the company utilizes a portable scanner to capture extensive data about artworks, ensuring accurate and detailed visualizations. Artmyn provides an array of services such as online galleries, interactive guided tours, educational resources, and conservation monitoring tools, catering to museums, galleries, auction houses, and both private and institutional collectors. By enhancing the art viewing experience, Artmyn facilitates greater transparency and engagement for art buyers and enthusiasts alike.

Domo Health is a Swiss company transforming healthcare through its innovative digital health platform that connects patients to their local care environment. Powered by real-world data and AI, we enhance personalized and preventive care at home. With our SaaS clinical platform, domo.health, we monitor patients' conditions, offer safety solutions, and empower professionals to make informed decisions. Together, we're shaping a future focused on safer and healthier in-home experiences.

CodeCheck AG is a Swiss company based in Zurich that has developed a smartphone application designed to help consumers make informed purchasing decisions. Founded in 2007, the CodeCheck app allows users to scan the barcodes of food and cosmetic products in Germany and the USA, providing detailed product descriptions, ingredient lists, and consumer reviews. It offers personalized ratings based on individual user profiles and the latest scientific research, catering to the growing demand for transparency regarding product ingredients and ethical standards. With a user base exceeding 3 million, CodeCheck taps into significant trends in conscious consumption and transparency. Additionally, the company has introduced Oeeda, a market research solution aimed at assisting manufacturers in understanding consumer preferences to drive innovation.

LEND is a peer-to-peer lending platform based in Switzerland, founded in 2015. The company connects investors with borrowers, facilitating transactions for private and small to medium-sized enterprise (SME) loans and mortgages. Through its online platform, LEND enables investors to finance borrowers directly, allowing them to build diversified portfolios by investing small amounts in multiple loans. This approach provides borrowers with access to low-interest loans while offering investors the opportunity to earn substantial returns on their investments.

Saphetor SA, founded in 2014 and based in Lausanne, Switzerland, specializes in data-driven solutions aimed at enhancing diagnostics and therapy selection for cancer and challenging medical conditions, including rare diseases and cognitive impairments. The company's flagship platform, VarSome, serves as a comprehensive resource for human genome data, offering extensive variant analyses that assist healthcare professionals in accurately identifying genetic causes of diseases. By facilitating the selection of targeted therapies, stratifying patients for clinical trials, and supporting drug development through sub-population analysis, Saphetor plays a critical role in modern precision medicine. Its technology also aids in the discovery and validation of new drug targets and biomarkers, significantly improving patient outcomes and healthcare practices globally.

NetGuardians SA is a software company that specializes in fraud prevention and risk mitigation solutions for the banking and financial services sectors. Founded in 2007 and based in Yverdon-les-Bains, Switzerland, with additional offices in Nairobi, Warsaw, and Singapore, the company utilizes big data and behavioral analytics to address various fraud challenges, including mobile banking and identity theft. Its key offerings include FraudGuardian, which provides predefined controls for continuous auditing of user behavior across multiple channels, and RiskGuardian, an automation tool for compliance that features regulatory templates, automated updates, and reporting capabilities. NetGuardians serves a diverse clientele, including CIOs, CISOs, internal auditors, and compliance professionals, primarily in Europe, the Middle East, Asia, and Africa, and distributes its products through resellers.

BugBuster is a Switzerland-based startup that originated as a spinoff from the Operating Systems Laboratory at EPFL. The company aims to revolutionize application testing by minimizing the dependence on manually written test cases. By utilizing code analysis, BugBuster seeks to automate the testing process, significantly reducing the effort required for testing applications. Additionally, the company offers smart automated testing for websites and web applications through a cloud-based platform, enhancing efficiency and accuracy in the testing workflow.

SmallRivers develops web services that are facilitating the interconnection of people around shared interests. SmallRivers is a privately held startup incorporated in Switzerland (Lausanne) and located on the Swiss Federal Institute of Technology EPFL campus, Scientific Park.

Abionic SA is a Swiss company specializing in nanotechnology-based diagnostic solutions aimed at enhancing medical diagnosis. Founded in 2010 as a spin-off from the Swiss Federal Institute of Technology Lausanne (EPFL), Abionic has developed the abioSCOPE platform, which enables rapid testing of patients' allergy profiles using just a single drop of blood. This innovative platform includes a reader for nanofluidic sensors and a smartphone application, facilitating both clinical laboratory use and point-of-care testing. Abionic's products are designed to assist healthcare professionals in diagnosing and screening various medical conditions, particularly in the realms of allergy and sepsis. The company is ISO 9001/13485 certified, demonstrating its commitment to quality management in the development and commercialization of in vitro diagnostic devices. With strategic support from various Swiss institutions, Abionic aims to become a significant player in personalized medicine on an international scale. The company is headquartered in Lausanne, Switzerland.